Detalles de la búsqueda
1.
Treatment and prognosis of primary pulmonary lymphoma: A long-term follow-up study.
Eur J Haematol
; 106(1): 49-57, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32779796
2.
One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab.
Eur J Haematol
; 106(3): 389-397, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33301613
3.
Non-scarring patchy alopecia: What else, apart from alopecia areata?
J Cutan Pathol
; 48(10): 1282-1285, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34036615
4.
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients.
Eur J Haematol
; 104(2): 138-144, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31762088
5.
Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemia.
Am J Hematol
; 95(11): 1304-1313, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32697337
6.
Influence of Donor and Recipient Gender on Telomere Maintenance after Umbilical Cord Blood Cell Transplantation: A Study by the Gruppo Italiano Trapianto Di Midollo Osseo.
Biol Blood Marrow Transplant
; 25(7): 1387-1394, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30935966
7.
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group.
Biol Blood Marrow Transplant
; 25(5): 932-940, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30579966
8.
Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM.
Blood
; 127(23): 2833-40, 2016 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27091875
9.
Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR.
Haematologica
; 103(12): 2079-2087, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30237264
10.
"Best practice" for extracorporeal photopheresis in acute and chronic graft-versus-host disease by Societa' Italiana di Emaferesi and Manipolazione Cellulare and Gruppo Italiano Trapianto Midollo Osseo: a national survey to ascertain its degree of application in Italian transplant centers.
Transfusion
; 58(1): 217-222, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29134658
11.
Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT.
Am J Hematol
; 93(12): 1532-1542, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30218444
12.
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen.
Biol Blood Marrow Transplant
; 23(7): 1102-1109, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28390983
13.
CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features.
Haematologica
; 102(3): 529-540, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28250006
14.
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment.
Hematol Oncol
; 35(1): 69-78, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26251194
15.
High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry.
Biol Blood Marrow Transplant
; 22(3): 475-81, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26723932
16.
Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 122(12): 1880-7, 2016 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27018549
17.
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia.
Blood
; 123(10): 1552-5, 2014 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24371211
18.
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.
Blood
; 123(15): 2333-42, 2014 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24558201
19.
New patterns of relapse in multiple myeloma: a case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation.
Clin Chem Lab Med
; 54(6): 991-5, 2016 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26581069
20.
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 16(15): 1525-1536, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26429297